StonvexLoading…
StonvexStonvexStonvexCore line items from AMCR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $17.11B | $11.19B | $5.75B | $15.01B |
Operating Income | $1.25B | $792.00M | $461.00M | $1.01B |
Net Income | $717.00M | $439.00M | $262.00M | $511.00M |
EPS (Diluted) | $1.55 | $0.95 | $0.11 | $0.32 |
Total Assets | $37.58B | $37.05B | $37.15B | $37.07B |
Total Liabilities | $25.92B | $25.40B | $25.42B | $25.33B |
Cash & Equivalents | $1.59B | $1.06B | $825.00M | $827.00M |
Free Cash Flow OCF − CapEx | $-131.00M | $-89.00M | $-371.00M | $810.00M |
Shares Outstanding | 463.50M | 463.00M | 2.31B | 1.59B |